BMO plans 8.1% autocallable cash-settled notes linked to biotech ETF

By Wendy Van Sickle

Columbus, Ohio, June 9 – Bank of Montreal plans to price 8.1% autocallable cash-settled notes with fixed interest payments due June 30, 2017 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to an FWP filing with the Securities and Exchange Commission.

Interest will be payable monthly.

If the fund finishes above the 110% call level on any monthly call date, the notes will be called at par plus the coupon.

The payout at maturity will be par unless the fund finishes below the 75% trigger level, in which case investors will be fully exposed to any losses.

BMO Capital Markets Corp. is the agent.

The notes will price on June 27 and settle on June 30.

The Cusip number is 06367TFN5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.